Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Trial Research
Imagenetix, Inc. Successful in Trademark Dispute Against CetylMax for Unauthorized Marketing Use of Celadrin(R) Clinical Studies
March 21st, 2009
Imagenetix, Inc. (OTC Bulletin Board: IAGX), manufacturer of Celadrin(R), a proprietary cellular lubricant for joint comfort, announced that it has prevailed in its efforts to prevent competitors CetylMax, LLC and Flexadren, LLC from making unauthorized references to Celadrin(R) clinical studies in marketing their products. Celadrin(R), comprised of a unique cetylated fatty acid carbon matrix, is used to promote joint health and is available in oral and topical forms. Imagenetix filed a federal trademark infringement lawsuit against CetylMax and Flexadren on July 29, 2008, in the United States District Court, Southern District of California. Imagenetix asserted the...
Source: Law & Health Weekly (2009-03-21)
|
